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W e have extensively purified the release factors Rj and 
R 2 from Escherichia coli. T hese proteins can each m ediate 
polypeptide chain termination. The physiological substrate 
for this reaction is a completed polypeptide chain in a pep- 
tidyl-transfer RNA-m essenger RNA-ribosome complex. 
The reaction consists of recognition of a chain-terminating 
signal in the mRNA and hydrolysis of the peptidyl-tRNA  
ester bond, releasing the polypeptide chain. For the purifi­
cation we were guided by two kinds of assay, the hexapep- 
tide release assay and the formylmethionine release assay, 
each named according to the m olecule released in a model 
reaction analogous to physiological chain termination. The 
two factors have different codon specificities, Ri acting in 
response to UAG or UAA, and R 2 in response to UGA or 
UAA.
Both factors were purified from a 1-kg batch of frozen 
E. coli MRE600 by a scheme which carried the material 
through four steps before reaching a branch point at the 
fifth step, when Ri- and R 2-rich fractions were produced. 
The two fractions were then treated similarly but separately 
through three more steps.
The products were studied by polyacrylamide gel electro­
phoresis using both routine and sodium dodecyl sulfate tech­
niques. For the 6.4 mg of purified Ri, we estim ate 85% 
purity after 2,000-fold purification. For the 9.4 mg of puri­
fied R 2, we estimate 99% purity after 1,500-fold purification. 
Our results indicate that each release factor consists of a 
single polypeptide chain with a molecular weight of 44,000 
for Ri and 47,000 for R 2. W e calculate that there are about 
500 m olecules of Ri and 700 m olecules of R 2 per E. coli cell.
When all the elongation steps are completed in the biosynthe­
sis of a polypeptide chain, the chain retains an ester linkage to 
the transfer RN A  of the last (carboxyl-terminal) amino acid
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residue and, by virtue of this bond, is part of a complex with the 
messenger RNA and ribosome. The ribosome, having traversed 
a series of amino acid-designating codons in the mRNA, has 
reached a chain-terminating signal. When this signal is recog­
nized, hydrolysis of the final peptidyl-tRNA ester linkage occurs, 
releasing the polypeptide chain. The recognition and hydroly­
sis events constitute the polypeptide chain term ination reaction. 
The release factors from Escherichia coli, R i and R 2, are proteins 
each of which can mediate this kind of reaction (1, 2).
Whereas the physiological reaction term inates completed poly­
peptide chains, the release factors were originally shown by their 
mediation of two analogous reactions, with shorter released 
products. The analogous reactions form the bases of the hexa- 
peptide release assay (3) and the formylmethionine release assay
(4), each named according to the molecule released. They 
make use of the trinucleotide sequences, UAA,1 UAG, and UGA, 
known to be able to code for termination. Relying on these 
assays, we have extensively purified R x and R 2 by a scheme which 
is summarized in Table I.
The hexapeptide release assay uses mRNA from an amber 
m utan t of the RNA coliphage R17 (amB2), in which the seventh 
codon in the viral coat protein gene, CAG, has m utated to the 
chain term inating codon, UAG. By virtue of its altered coding 
properties, this RNA can be used in a protein-synthesizing scheme 
in vitro to construct a relatively simple substrate for release fac­
tor action. The substrate consists of the amino-terminal hexa­
peptide of the coat protein (fM ET-A la-Ser-A sn-Phe-Thr) com- 
plexed with tRNA, ribosome, and mRNA, with UAG in position 
to be read. One can assay for the activity of R i by incubating 
this complex with protein fractions and measuring the am ount of 
hexapeptide released (and also the am ount remaining bound).
In  the formylmethionine release assay developed by Caskey 
et al. (4), the mRNA function is performed by two trinucleotides 
used in succession to signal initiation and termination. The 
substrate is formed by first making a complex of ribosome, AUG 
(the initiator triplet), and fM ET-tRNA. Then a release triplet 
and test protein are added, and release of free formylmethionine 
is measured. The different codon specificities of the two release 
factors are reflected in this assay, as shown by Scolnick et al.
(5). Thus, R i mediates the reaction in response to UAG or 
UAA, and R 2 in response to UGA or UAA. This explains why
1 An abbreviation  of the type UAA signifies e ither a trinucleo­
side diphosphate of the  type UpApA or the sam e sequence occur­
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the hexapeptide release assay detects only li i, for it depends on 
the codon UAG in the mutated ENA. The formylmethionine 
release assay can be used to detect R i, R 2, or the sum of their 
activities, depending on the choice of the terminator triplet 
(UAG, UGA, or UAA, respectively).
Recent studies of release factor action with both wild type and 
mutant viral messengers to direct protein synthesis confirmed 
the terminator triplet specificities of R i and R2 (1) and, further, 
showed that the factors mediate normal, physiological termina­
tions (1, 2). The analogous reactions remain useful for routine 
assay purposes.
MATERIALS AND METHODS
Commercial Materials—Bio-Solv was purchased from Beck- 
man-Spinco; ATP, GTP, bovine serum albumin (crystalline, A 
grade), dithiothreitol (A grade), P-enolpyruvate, and pyruvate 
kinase from Calbiochem; Casamino acids from Difco Labora­
tories, Inc.; acrylamide (recrystallized), iV,iV'-methylenebis- 
acrylamide, and glycine (ammonia-free) from Eastman; isopro­
pyl alcohol (Spectranalyzed) from Fisher; calcium leucovorin 
from Lederle Laboratories; and (NH4)2S04 (special enzyme 
grade), alanine, asparagine, methionine, serine, and threonine 
from Mann. Glycerol (Spectroquality) was a product of Mathe- 
son Coleman and Bell, East Rutherford, New Jersey, as was 
sodium dodecyl sulfate which we recrystallized out of acetone. 
AUG, UAA, UAG, and UGA were obtained from Miles Labs, 
Elkhart, Indiana; levigated alumina from Norton Company, 
Worcester, Massachusetts; DEAE-Sephadex A-50, Sephadex 
G-25, Sephadex G-100, and Dextran T 500 from Pharmacia; 
DEAE-cellulose (Whatman, microgranular, DE-52) from Reeve 
Angel Company, New York; 14C-phenylalanine (300 mCi per 
mmole) and 3H-methionine (3 Ci per mmole) from Schwarz Bio­
Research; Tris base and Tris-HCl from Sigma; and polyethylene- 
glycol (PEG) (Carbowax 6000) from Union Carbide and Carbon 
Corporation, New York.
Hexapeptide Release Assay—To synthesize the substrate for 
assaying 30 samples, a 500-/ul reaction mixture wras prepared 
containing 50 mM Tris-HCl, pH 7.8; 11 mM MgC'l2; 50 mM 
NH4C1; 4 mM dithiothreitol; 2.7 mM ATP; 0.14 niM GTP; 0.75 
mg of P-enolpyruvate; 20 jug of pyruvate kinase; 20 nmoles each 
of methionine, alanine, serine, and asparagine; 1.5 /uCi of 14C- 
phenylalanine; 0.5 mg of tRNA; 60 ng of calcium leucovorin;
0.9 mg of E. coli S26 supernatant proteins; 1.5 mg of E. coli S26 
ribosomes; and 0.15 mg of amB2 RNA. After incubation for 
15 min at 35°, the mixture was cooled in ice, combined with 300 
jul of Buffer A (50 mM Tris-HCl, pH 7.6; 60 mM KC1; 10 niM 
MgCl2; 0.5 mM EDTA; 2 mM dithiothreitol), layered on a 12-ml 
linear sucrose gradient (10% to 30% with 50 mM Tris-HCl, pH 
7.5; 60 mM KC1; 10 mM MgCl2; 0.5 mM EDTA; and 1 mM dithio­
threitol), and centrifuged with the International SB283 rotor at
40,000 rpm for 185 min at 4°. The sucrose gradient centrifuga­
tion is necessary to eliminate supernatant release factors before 
supplying the sixth amino acid of the hexapeptide. Fractions 
were collected from the bottom, and all material sedimenting 
faster than about 70 S (judged from the ribosomal absorbance 
pattern) was pooled.
This material, containing a pentapeptidyl-tRNA-ribosome- 
mRNA complex, was combined with 0.4 mg of threonyl-tRNA, 
] .8 ^moles of GTP, and 0.3 mg of T-factor to allow incorpora­
tion of the carboxyl-terminal amino acid of the hexapeptide 
fragment and completion of the substrate. The mixture was
made up to 7.75 ml with Buffer A. Portions (250 ,ul) were 
added to protein samples of 5- to 20-yul volume, followed by 
incubation at 35° for 12 min. The samples were cooled in ice, 
combined with 500 iA of 5% trichloracetic acid, and further 
processed to determine quantitatively released and bound hexa­
peptide as previously described (6).
Because synthesis of a stable substrate requires withholding 
the threonyl residue until after sucrose gradient centrifugation, 
the supernatant proteins must be free of amino acids and amino- 
acyl-tRNA. For such a protein preparation, we ground 15 g of 
frozen E. coli S26 in a mortar with 30 g of alumina and then 
worked up the paste in 50 ml of Buffer B (50 mM Tris-HCl, pH 
7.6; 5 mM MgCl2; 0.5 nm EDTA; 1 niM dithiothreitol; 20% 
glycerol). Debris was centrifuged out in two successive cen­
trifugations, 12,000 X g for 30 min and 30,000 X g for 30 min. 
The supernatant fluid was made up to 50 ml with Buffer B. 
Polymer solutions and salt were added with stirring over the 
course of 45 min as follows: 20%, dextran, 5.8 ml; 30%, poly- 
ethyleneglycol, 15.5 ml; NaCl, 16.5 g (7). After another hour 
of stirring, two aqueous phases were separated by centrifugation 
at 4,300 X g for 5 min. The upper phase w'as dialyzed against
4 liters of Buffer C (50 mM Tris-HCl, pH 7.6; 5 mM MgCb; 0.5 
mM EDTA; 1 mM dithiothreitol; 5% glycerol) for 2 hours. Then 
(NH4)2S04 (19.2 g) was added to the 98-ml sample (for 33%, 
saturation). After 30 min of stirring, two phases wrere separated 
by centrifugation at 7,700 X g for 10 min. The lower phase,
93.8 ml, was transferred by siphoning with polyethylene tubing 
and treated by addition of 16.6 g of (NH4)2S04 (for 60% satura­
tion). After 45 min of stirring, the precipitated proteins wrere 
collected by centrifugation at 12,000 X g for 30 min and dis­
solved in 10 ml of Buffer D (50 mM Tris-HCl, pH 7.6; 5 mM 
MgCl2; 0.5 mM EDTA; 1 mM dithiothreitol; 50% glycerol). The 
supernatant proteins were finally dialyzed against Buffer D for 2 
hours, with 600 ml in two portions. The product was stored in 
a —20° freezer.
E. coli S26 ribosomes were prepared as described previously 
(3) from a 30,000 X g supernatant fraction by sedimentation 
through a solution containing 50 mM Tris-HCl, pH 7.6; 10 mM 
MgCI2; 0.10 m NH4CI; 1 nw EDTA; and 0.5 mM dithiothreitol.
E. coli S26 tRNA was prepared as described previously (8).
The mutant phage amB2 was grown and purified according to 
the procedure of Gesteland and Boedtker (9) with the permissive 
E. coli strain S26R1E. The RNA was purified as described 
previously (8) by phenol extraction and ethanol precipitation.
E. coli threonyl-tRNA was partially purified by the method 
of Weiss, Kelmers, and Stullberg (10) with reverse phase chroma­
tography. It was then charged with threonine by supernatant 
proteins, deproteinized with phenol, and chromatographed on 
Sephadex G-25.
The transfer factor, T, was obtained from DEAE-Sephadex 
chromatography of supernatant proteins and identified by com­
plementation of G-factor in a poly-U-dependent polyphenylala­
nine-synthesizing system, and by binding of GTP.
Formylmethionine Release Assay—This assay was done by the 
method of Caskey et al. (4). The fiVIet-tRNA-AUG-ribosome 
complex was formed by incubating, for 15 min at 25°, a 100-//.1 
reaction mixture containing: 50 mM Tris-HCl, pH 7.2; 11 mM 
MgCl2; 0.10 m NH 4CI; 1 mg of E. coli MRE600 ribosomes 
(washed with 0.5 m NH4C1); 10 pmoles of f-3H-met-tRNAfMet; 
and 4 nmoles of AUG. For each release reaction, 4.5 /il of the 


















Issue o f F e b ru a ry  25, 1971 H. A. Klein and 21/. B. Capecchi 1057
§
a&
mixture containing: 50 mM Tris-HCl, pH 7.2; 30 mM MgCl2; 0.10 
m NH4CI; 1 mM dithiothreitol; J nmole of UAG, UGA, or UAA; 
and protein sample. The reaction was stopped by cooling and 
addition of 250 yul of 0.1 n HC1. The released formyl-3H-methio- 
nine was partitioned into 1.4 ml of ethyl acetate, and a 1.0-ml 
sample was counted in toluene-fluor with Bio-Solv. Unlike the 
hexapeptide release assay, the formylmethionine release assay 
was performed with no transfer factors or GTP and with only 
one species of tRNA present.
tRNAfMet was prepared by Oak Ridge National Laboratories 
under Atomic Energy Commission-National Institute of General 
Medical Sciences NIGMS interregional agreement and distrib­
uted by National Institute of General Medical Sciences.
Comments on Assays—By way of comparing the two kinds of 
assay, the hexapeptide release assay, with a viral mRNA, can be 
considered to approximate better the physiological termination 
reaction. On the other hand, the formylmethionine release 
assay is more rapid and convenient. Both kinds of assay were 
useful for evolving the details of the purification scheme.
When we used the assays to evaluate protein fractions ob­
tained at various stages of purification, the extent of reaction in 
a standard time interval was routinely determined as a function 
of varying amounts of the protein sample. For purified release 
factors, this function increased linearly up to extents of reaction 
in which the substrate was no longer saturating. However, for 
relatively impure fractions, with either kind of assay, this func­
tion showed downward curvature, attributable to inhibitors or 
interfering enzymes. Any deformylase or peptidase which left 
the labeled part of the release product with a free amino group 
could explain this effect, for the counts would be lost in the 
separation schemes which lead to final quantitation in each 
assay. Ability to obtain a linear region of protein dependence 
was our criterion for reliability of the assay for a given protein 
fraction. Judging in this way, we found the hexapeptide release 
assay to be reliable for Fraction III and all purer fractions of 
Ri; the formylmethionine release assay was reliable for Fractions 
Via and VIb and the purer fractions of both release factors. 
(Tabulated data obtained from assay of the less pure fractions 
are approximations based 011 the lowest amounts of protein 
assayed.)
The assay clata presented in any column of Table I compare 
samples assayed simultaneously and represent a reproducible 
relation among the specific activities of different samples. The 
results are not so meaningful in absolute terms, for they varied 
from assay to assay especially if different sets of components 
were used.
Calcium Phosphate Gel—  Calcium phosphate gel was prepared 
by a method based on that of Keilin and Hartree (11). The 
mixture, 0.6 m CaC'l2-H20  (150 ml), was made up to 1600 ml 
with distilled water, and 0.4 m Na3P0 4 -II20  (1.50 ml) was added 
drop wise with stirring. The mixture was brought to pH 7.4 
with 10% acetic acid. We washed the precipitate many times 
with distilled water, letting it settle and decanting. Finally, 
the gel was sedimented at 4300 X g for 15 min in 50-ml centri­
fuge tubes and then homogenized with Buffer E (50 mM Tris- 
IICl, pH 7.0; 0.1 m KC1; .1 mM dithiothreitol) with a Teflon 
pestle which fit the tubes with 1mm clearance. In this manner, 
the gel was w'ashed three times with Buffer E, with 253 ml per 
wash. Finally, one batch of sedimented gel weighed 65 g. On 
this wet weight basis, 30.3 g of gel were used per gram of protein 
to be adsorbed.
Growth of Bacteria—E. coli MRE600, a B strain lacking RNase
I, was used. The medium was 20 mM KH2P 04; 80 mM K2HPO4; 
1 mM MgCl2; 15 mM (NH4)2S04; Casamino acids, 4 g per liter; 
and glucose, 10 g per liter. The cells were grown to late log 
phase in 100 liters in a Fermacell fermentor (New' Brunswick 
Scientific Company, Inc., New Brunswick, New Jersey) at 35° 
with aeration. They were collected with a Sharpies centrifuge 
and washed twice by suspension in Buffer F (50 mM Tris-HC'l, 
pH 7.4; 10 mM MgCl») and centrifugation at 5,000 X g for 25 
min. About 900 g of cells, wet weight, were obtained from each 
such session of growth, and they were stored at —70°.
Protein Determination—-Protein concentrations were deter­
mined from optical density at 280 m/x and 260 mju by the method 
of Warburg and Christian (12). For low concentrations, the 
method of Lowry et al. (13) was used, with crystalline bovine 
serum albumin as standard. For Fraction I, determination 
according to the method of Lowry was performed after treating 
the sample with DNase and RNase, precipitating with 5% tri­
chloracetic acid, and dissolving in 1 n NaOH.
Polyacrylamide Gel Electrophoresis—Routine runs, essentially 
following the method of Davis (14), were performed with 7.5% 
polyacrylamide gels (6 X 56 mm) which were buffered with
0.375 m Tris-HCl (pH 8.9) and topped with 13-mm high spacer 
gels containing 2.5% polyacrylamide, 29 mM Tris base and 16 
mM H3PO4 (pH 7.1). Samples were diluted into 24 mM Tris 
base, 13 mM PI3PO4, 10% glycerol (pH 7.1), layered on to the 
gels, and subjected to electrophoresis at 4° with a reservoir 
buffer of 9.9 mM Tris base, 77 mM glycine (pH 8.4). The gels 
were run at 2.5 ma per gel, with migration toward the anode, 
for 135 min and stained with Coomassie brilliant blue.
Sodium dodecyl sulfate gels followed the method of Shapiro, 
Vinuela, and Maizel (15). The gels, 6 X 58 mm, contained 
7.5% polyacrylamide, 0.1 m sodium phosphate, 0.1% sodium 
dodecyl sulfate (pH 7.3). Protein samples were diluted into 13 
mM sodium phosphate, 0.14% sodium dodecyl sulfate, 1.3% 
2-mercaptoethanol (pH 7.4) and incubated for 2 hours at 37°. 
Each sample was then made 20% in glycerol and had 1 /ig of 
bromphenol blue dye added before application to the top of the 
gel. Electrophoresis was at room temperature (25°) with a 
reservoir buffer of 75 mM sodium phosphate, 0.075% sodium 
dodecyl sulfate (pH 7.2). The gels were run at 8 ma per gel 
with migration toward the anode until the dye was near the 
bottom at about 265 min. They were stained with Coomassie 
brilliant blue.
RESULTS
Both release factors were purified from a batch of E. coli by a 
scheme (Table I) which carried the material through four steps 
before reaching a branch point at the fifth step, when Ri- and 
R2-rich fractions were produced. They wyere treated similarly 
but separately through the rest of the purification. Procedures 
were performed in a 4° cold room. Volumes and pH values for 
the preparation of solutions are room temperature values (25°). 
Double distilled water was used.
Purification of R 1
Step 1: Crude Extract—-Frozen E. coli MRE600 (1 kg) was 
homogenized in a Waring Blendor with 1 liter of Buffer G (50 
mM Tris-HCl, pH 7.6; 5 mM MgCl2; 0.5 mM EDTA; 1 mM dithio­
threitol; 15% glycerol). When the homogenate had warmed to 
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T able I
Scheme fo r  purifica tion  o f release factors, R i and R 2, fro m  E scherich ia  coli
Purification  of R i and R 2 from 1 kg of frozen E . coli. The cal­
cium phosphate gel step  is the  b ranch  po in t in  the scheme, yield­
ing two fractions enriched for R i and R 2, respectively, w hich 
are trea ted  sim ilarly  b u t separately  through the res t of the  
purification. T he hexapeptide release assay w as used to  de te r­
mine the ac tiv ity  of R i fractions ( I I I  th rough  V il la ) .  The for- 
m ylm ethionine release assay was also applied to  R j fractions, w ith  
UAG and UAA, as indicated , as the term inato r trinucleotides. 
T he la tte r  assay w as applied to  R 2 fractions ( I I I  th rough  V U Ib) 
w ith  UGA and UAA, as indicated . The ac tiv ities of F raction  
V i l l a  w ith  UGA and F raction  V U Ib  w ith  UAG were negligible.
F ractions I and I I  could not be reliably  assayed. Since only 
approxim ate d a ta  could be obtained by th e  form ylm ethionine 
release assay for the next three stages, these are given in  paren ­
theses. Specific ac tiv ities of the release fac to rs are given as the 
num ber of picomoles of p roduct released per m in per mg of p ro ­
te in  assayed. T o ta l ac tiv ities given for the  release fac to rs are 
based, for R j, on the resu lts of the hexapeptide release assay and, 
for R 2, on the resu lts of th e  form ylm ethionine release assay using 
UGA. We estim ate  an over-all degree of purifica tion  (relative 
to  F raction  I) of 2000-fold for R i and 1500-fold for R 2.
Step




Specific activity (formylmethionine) Total activity
Ri r 2 Ri R= Ri UAG Ri UAA R2 UGA R2 UAA Ri Rj
mg pmole/min/ mg pmole/tninj mg pmole/min
Crude e x tra c t.......................................... I 77, 500
Aqueous po lym ers.................................. I I
D EA E -cellulose...................................... I I I 5, 770 10.4 (0.75) — (1.48) — 60,000 (8,550)
(M l, .  ..SO ,.................................................... IV 2 , 540 19.8 (1.17) (2.91) — 50,300 (7,400)
Calcium  phosphate  g e l ........................ Va Vb 665 552 44.7 (2.71) — (7.8) — 29,700 (4,310)
Isopropyl alcohol................................... V ia VIb 238 330 102 8.3 9.4 10.9 14.6 24,300 3,600
Sephadex G-100 .................................... V ila V llb 33 59 561 46.2 58.0 46.6 48.0 18,500 2,750









by two passes through a Gaulin Mill under 8,000 p.s.i., followed 
by a 200-ml rinse of the mill with Buffer G. This process raised 
the temperature to 20°. Debris was removed by centrifugation 
at 10,000 X g for 50 min.
Step 2: Aqueous Polymer Partitioning—-The supernatant fluid 
(Fraction I, containing 77.5 g of protein) was treated by parti­
tioning between dextran and polyethyleneglycol in the manner 
of Albertsson (7) to remove ribosomes, the bulk of the free 
nucleic acid, and a portion of protein. For this purpose, the 
crude extract (1,600 ml) was stirred with gradual addition of the 
polymers and salt to the desired concentration i.e., 20% dextran, 
168 ml; 30% polyethyleneglycol, 462 ml; NaCl, 326 g. After a 
total of 55 min of stirring, the phases were separated by centrifu­
gation at 10,000 X g for 15 min. The lower, dextran-rich, phase 
was discarded.
Step 8: DEAE-cellulose Chromatography—For application to 
the ion exchange column, the upper, polyethyleneglycol-rich 
and protein-rich phase (Fraction II, 1940 ml) was dialyzed in 
bags of 21-mm diameter against Buffer H (25 mM Tris-HCl, pH 
7.6; 0.5 mM EDTA; 0.5 mM dithiothreitol). A total of 29 liters 
of Buffer H were used in three portions over 6 hours. The con­
ductivity of the protein solution was finally checked to make sure 
that it was lower than that of Buffer I (25 mM Tris-HCl, pH 
7.6; 0.1 m KC1; 0.5 mM EDTA; 1 mM dithiothreitol; 5% glyc­
erol). A small amount of precipitated polyethylene glycol was 
removed by centrifugation at 10,000 X g for 45 min. The super­
natant fluid (3 liters) was fed on to the column over 18 hours. 
The column, which had been equilibrated with Buffer I, had a 
bed of microgranular DEAE-cellulose, 9.5 cm high and 8.7 cm 
in diameter.
The polyethyleneglycol and some protein passed through the 
column during the application and a wash with Buffer I, 800 ml. 
The protein remaining adsorbed was eluted in two steps, carried 
out with a flow rate of 7.2 ml per min and collecting 20.8-ml
fractions. First, elution with 980 ml of Buffer J  (25 mu Tris- 
HCl, pH 7.6; 0.145 m KC1; 0.5 mM EDTA; 1 mM dithiothreitol; 
5% glycerol) yielded fractions containing 8840 mg of protein, 
which were discarded. Then, elution with 980 ml of Buffer K 
(50 mM Tris-HCl, pH 7.6; 0.26 m KC1; 0.5 mM EDTA; 0.5 mM 
dithiothreitol; 5% glycerol) yielded fractions containing 5770 
mg of protein. The elution with Buffer K was followed by 
elution with Buffer L (25 mM Tris-HCl, pH 7.6; 0.6 m KC1; 0.5 
mM EDTA) in order to complete the recovery of the Buffer K. 
The material was pooled (Fraction III) for further processing.
Step If.: (NH^^SOt Fractionation—-Fraction III was precipi­
tated by gradually adding 446 g of solid (NH^SOi (for 70% 
saturation) to the 959-ml eluate, with stirring. After an addi­
tional 45 min of stirring, the precipitate was collected by centrifu­
gation at 25,000 X g for 40 min, and a protein fraction containing 
the release factors was extracted from it with (NH4)2S0 4 solu­
tions. These had been prepared by adding (NH4)2S04 to meas­
ured volumes of Buffer Al (50 mM Tris-HCl, pH 7.3; 1 mM di­
thiothreitol). First, the sediment was worked up in 940 ml of 
Buffer N (277 g of (NH4)2S04 per liter of Buffer M, for 45% 
saturation), followed by stirring for 45 min and centrifugation 
at 25,000 X g for 40 min. The supernatant fluid was set aside, 
and the sediment was then worked up, with the aid of a Dounce 
homogenizer, in 455 ml of Buffer 0  (256 g of (NH4)2S04 per liter 
of Buffer M, for 42% saturation), followed by stirring and cen­
trifugation as before. The two supernatant fluids were pooled, 
giving a volume of 1492 ml (including additional amounts of 
Buffers N and 0  which were required to fill the centrifuge 
bottles). Solid (NH4)2S04, 95.6 g, was added slowly to give 
about 55% saturation to precipitate Fraction IV, which was 
collected, after 45 min of additional stirring, by centrifugation 
at 25,000 X g for 40 min.
Step 5: Calcium Phosphate Oel Fractionation—Eraction IV was 


























3,500 ml of Buffer E in two portions. The fraction contained 
2,540 mg of protein in 75 ml, and on this basis 77 g of calcium 
phosphate gel were homogenized with 193 ml of Buffer E and 
slowly added to the protein solution for adsorption. Protein 
fractions were later eluted from the gel with 268-ml portions of 
buffers of increasing phosphate concentration. The gel was 
homogenized with Buffer E and with the elution buffers in 15 
50-ml centrifuge tubes with a Teflon pestle just as in the last 
steps of preparing the gel (see above). At each step (adsorption 
and elution), the homogenate was stirred for 45 min and centri­
fuged at 4,300 X g for 15 min to pellet the gel. Elution was 
performed twice with Buffer P (10 nm potassium phosphate, 
pH 7.0; 1 mM dithiothreitol), twice with Buffer Q (45 mM po­
tassium phosphate, pH 7.0; 1 mM dithiothreitol), and once each 
with Buffer R (80 mM potassium phosphate, pH 7.1; 1 mM 
dithiothreitol) and Buffer S (0.12 M potassium phosphate, pH 
7.1; 1 mM dithiothreitol). The fractions obtained with Buffer 
Q were pooled to give Fraction Va, which was rich in Ri; the 
fractions obtained with Buffers R and S were pooled to give 
Fraction Yb, which was rich in R2. Tris-HCl (1 m, pH 8.0, 
27.3 ml) was added to Fraction Va (519 ml), and the protein was 
precipitated by gradual addition of 258 g of solid (NH^SC^ 
(for 70% saturation). After 45 min of stirring, the protein was 
sedimented at 25,000 X g for 40 min. Fraction Vb was treated 
in the same manner.
Step 6: Isopropyl Alcohol Fractionation—-Fraction Va (665 mg) 
was taken up in 13.9 ml of Buffer T (50 mM Tris-HCl, pH 6.9; 
50 mM MgCl2; 0.5 mM EDTA; 1 mM dithiothreitol and dialyzed 
against the same buffer for 2 hours, wdth 1,200 ml in two por­
tions. A precipitate was removed by centrifugation at 12,000 X 
g for 20 min. The solution was brought to 60.8 ml with Buffer 
T, and 17.2 ml of isopropyl alcohol was added over 25 min with 
stirring (for 22% concentration). The solution was in a steel 
beaker held at 0° while receiving the first 6.8 ml of isopropyl 
alcohol (10%), at —6° in a refrigerated bath for the remainder. 
The lower temperature was maintained during another 10 min 
of stirring and during centrifugation at 29,000 X g for 20 min.
Step 7: Sephadex G-100 Chromatography—The sedimented 
protein (Fraction Via) was taken up in 2.7 ml of Buffer U (50 
mM Tris-HCl, pH 7.4; 0.15 m KC1; 1 mM EDTA; 2 mM dithio­
threitol) and dialyzed against the same buffer for 2 hours, with 
500 ml in two portions. Insoluble material was removed by 
centrifugation at 12,000 X g for 30 min. The supernatant fluid 
(238 mg in 4.5 ml) was applied to a column of Sephadex G-100, 
2.5 X 200 cm, and eluted with Buffer U  at 0.35 ml per min. 
Fractions of 3.5 ml were collected and assayed for Ri by the 
formylmethionine release assay. Active fractions were pooled 
as Fraction Vila.
Step 8: DEAE-Sephadex Chromatography—Fraction Vila 
(33.2 mg in 60 ml) was applied over the course of 150 min to a 
column of DEAE-Sephadex, 1.5 X 20 cm, which had been 
equilibrated with Buffer U. A linear gradient, progressing from 
Buffer U to Buffer V (50 mM Tris-HCl, pH 7.6; 0.50 m KCl; 1 
mM EDTA; 2 mM dithiothreitol) in a total volume of 500 ml, 
was applied to elute the proteins. A flow rate of 0.4 ml per min 
was maintained. Fractions of 3.0 ml wTere collected and assayed. 
The pooled, active fractions, which centered a t 0.28 m KCl, 
constituted Fraction V illa  (6.42 mg in 35.7 ml), the most highly 
purified fraction of Ri. This represents a 160-fold purification 
and 17.8% recovery in relation to Fraction III, the earliest frac­
tion reliably assayed by the hexapeptide release method. Since
Fraction III had a 13.4-fold reduction of the amount of protein 
in the crude extract (Fraction I), we estimate an over-all puri­
fication of about 2,000-fold.
In order to store R j in concentrated form, we added 5 mg of 
bovine serum albumin and then 15.3 g of (NH4)2S04 (for 65% 
saturation) to Fraction Villa. After 30 min of stirring, the 
precipitate was sedimented at 29,000 X g for 30 min, dissolved 
in 1.6 ml of Buffer W (50 mM Tris-HCl, pH 7.5; 0.15 m KCl; 
10 mM MgCl2; 1 mM EDTA; 2 mM dithiothreitol), and dialyzed 
against Buffer W, 1,000 ml in two portions, for 2 hours.
Purification of i?2
Steps 1 to 5 of the purification of Ri supplied Fraction Vb 
(552 mg), which was further processed to purify R2.
Step 6: Isopropyl Alcohol Fractionation—-This step was per­
formed exactly as for Fraction Va.
Step 7: Sephadex G-100 Chromatography—The sedimented 
protein (Fraction VIb) wras taken up in Buffer U, 7.6 ml, and 
dialyzed against the same buffer for 2 hours, with 500 ml in two 
portions. Insoluble material was removed by centrifugation at
12,000 X g for 30 min. The supernatant fluid was concentrated 
in a dialysis bag immersed in dry Sephadex G-200 to a volume 
of 5.3 ml. Precipitated protein was removed by centrifugation 
at 12,000 X g for 30 min. The supernatant fluid (330 mg) was 
applied to a column of Sephadex G-100, 2.5 X 200 cm, and 
eluted with Buffer U at 0.35 ml per min. Fractions of 3.5 ml 
were collected and assayed for R2 by the formylmethionine 
release assay. Active fractions were pooled as Fraction Vllb.
Step 8: DEAE-Sephadex Chromatography—-Fraction Vllb 
(58.5 mg in 65 ml) was applied over the course of 160 min to a 
column of DEAE-Sephadex, 1.5 X 20 cm, which had been 
equilibrated with Buffer U. A linear gradient progressing from 
Buffer U to Buffer X (50 him Tris-HCl, pH 7.6; 0.60 m KCl; 1 
mM EDTA; 2 mM dithiothreitol) in a total volume of 500 ml was 
applied to elute the proteins. A flow rate of 0.4 ml per min was 
maintained. Fractions of 3.0 ml were collected and assayed. 
The pooled, active fractions, which centered at 0.32 m KCl, 
constituted Fraction VUIb (9.42 mg in 34.9 ml), the most highly 
purified fraction of P 2. We estimate a 116-fold purification and 
19.0%, recovery in relation to Fraction III, based on the formyl­
methionine release assay with UGA. Reasoning as for Ri, this 
represents an approximate over-all purification of 1,500-fold 
over the crude extract (Fraction I). We added 5 mg of bovine 
serum albumin and then 15.0 g of (NH4)2S0 4  (for 65% satura­
tion) to Fraction VUIb. After 30 min of stirring, the precipi­
tate was sedimented at 29,000 X g for 30 min, dissolved in 1.7 
ml of Buffer W, and dialyzed against Buffer W, 1,000 ml in two 
portions, for 2 hours.
Characterization of Release Factors
Ri—On routine polyacrylamide gel electrophoresis, purified 
Ri (Fraction Villa) gave rise to a single major band and several 
minor bands (Fig. 1). The major band was estimated to ac­
count for 85% of the staining material. This band was identi­
fied as R i by the correlation of its intensity with R i activity of 
analyzed fractions. Electrophoretic analysis of purified Ri by 
the sodium dodecyl sulfate method also showed a major band 
and minor bands, the former again accounting for about 85% 
of the total and taken, therefore, to represent Ri (Fig. 2).
When proteins are analyzed by the latter method, they run as 
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Fig. 1 (left). Ri in the last three stages of purification analyzed 
by routine polyacrylamide gel electrophoresis. Migration was to­
ward the bottom (anode). The amounts of protein applied were: 
Via, 44 jig; V ila, 14 Mg; V illa , 6.3 Mg.
F i g . 2 (right). The purest fraction of each release factor ana­
lyzed by polyacrylamide gel electrophoresis using the sodium 
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(anode), R\ (Fraction V illa ) , 4.5 Mg, was applied to the first 
gel; l i t (Fraction V lllb ), 4.1 Mg. to the second. The third gel 
shows I{> subjected to coelectrophoresis with three of the markers 
used for molecular weight calibration (see Fig. 4). The markers 
and their single chain molecular weights are: A ,  catalase, 60,000;
B, carbonic anhydrase, 29,000; and C, R17 coat protein, 13,750.
F i g . 3. Calibration curve from the polyacrylamide gel electro­
phoresis of protein standards by the sodium dodecyl sulfate 
method. The molecular weights of dissociated polypeptide 
chains are plotted on a log scale as a function of mobility relative 
to that of R17 coat protein. The interpolated mobilities of Iti 
and R-. indicate molecular weights of 44,000 and 47,000, respec­
tively.
Fig. 4. Ri in the last three stages of purification analyzed by 
routine polyacrylamide gel electrophoresis. Migration was to­
ward the bottom (anode). The amounts of protein applied were: 
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inversely related to the logarithms of their molecular weights 
(15, 16). The results for Ri allowed us to infer that it consists 
of a single species of polypeptide chain with molecular weight of
44,000. The molecular weight estimate was obtained by running 
R i with a series of standard proteins of known dissociated chain 
molecular weights and measuring the distances migrated relative 
to that of the fastest standard, the Rl7 coat protein. A smooth, 
nearly linear curve of dependence on the logarithm of molecular 
weight w'as obtained (Fig. 3), allowing interpolation for the 
release factor. The behavior of R i on a calibrated sucrose 
gradient (3) and on the Sephadex G-100 column is consistent 
with the assignment of the molecular weight of the single chain 
to the native protein.
Ri—Purified R2 (Fraction VUIb) gave rise, on both routine 
(Fig. 4) and sodium dodecyl sulfate electrophoresis (Fig. 2), to a 
very predominant major band accounting for an estimated 99% 
of the staining material. On the routine gels, the band had a 
diffuse quality, possibly due to aggregation, but the band ob­
tained by the sodium dodecyl sulfate technique was sharp. In 
the same manner as for Ri, the single chain molecular weight 
was estimated at 47,000. Again, from our observation of the 
behavior of R2 on Sephadex G-100, we conclude that the native 
protein is a monomer of the same molecular weight.
DISCUSSION
Purification of the release factors enabled us to increase our 
understanding of their nature and their role in protein synthesis.
The efficacy of the purified factors as antigens permitted 
studies clarifying their physiological function (1). After chal­
lenging rabbits with them, we obtained highly specific antisera 
to each of the factors. We then found that the antisera could 
be used to control the release of the two detectable products of 
protein synthesis in vitro programmed with RNA from the coli- 
phage R 17, the coat protein and R NA synthetase. The addition 
of both antisera was necessary and sufficient to inhibit release of 
each phage protein, and either R i alone or R 2 alone, when added 
back in excess of the antisera, could overcome the inhibition 
and release the proteins. This result showed that the factors 
mediate normal terminations as well as the model reactions and 
was consistent with UAA signaling release at the termination 
loci for both the coat protein and the RNA synthetase, for it is 
the only codon to which both factors respond. UAA had been 
found, in fact, to occur at the terminus of the coat protein cis­
tron in the RNA sequence determined by Nichols (17).
In the present studies we observed that the behavior of both 
release factors through the fractionation scheme and electro­
phoretic analysis is entirely typical of proteins. Evidence 
against the presence of a nucleic acid portion includes the demon­
stration of resistance to RNase digestion (3, 4) and, in the case 
of R 1; a negative analysis for phosphorus (18). Establishing the 
chemical nature of the factors was important since they are 
probably the molecules which recognize the sequences coding 
for termination in mRNA (IS, 19).
One can envision a site in the ribosomal complex for codon 
recognition and another for reactions (peptide bond formation 
or hydrolysis) involving the carboxyl end of a growing or com­
pleted polypeptide chain. When the distance (not necessarily 
invariant) between these sites becomes known, it will be pertinent 
to compare it to the dimensions of Ri and R2 because of the 
involvement of the release factors in both recognition and hy­
drolysis. A ny molecule (such as am inoacyl-tR N A ) w-hich func­
tions sim ultaneously a t  bo th  sites m ust be long enough to  span 
the  distance. I f  the release factors are spheres of the  sta ted  
molecular weights, we estim ate a d iam eter of 47 A for each, 
w ith 1.4 g cm 3 for the ir density . T here is some question as to  
w hether the  release factors d irectly  catalyze hydrolysis of the 
pep tidy l-tR N A  ester bond. T he catalysis m ay be by  the  ribo­
som al pep tidy l transferase (the enzyme which forms the  peptide 
bonds), w ith  the  release factors acting  only to  trigger th is func­
tion  (18, 20 , 2 1 ).
F rom  our purification d a ta  we now estim ate th a t  there are 500 
molecules of R i and  700 molecules of R 2 per E . coli cell. The 
calculations used our p u rity  estim ates for F ractions V i l l a  (85% ) 
and  V U Ib  (9 9 % ), th e  molecular w eights (44,000 for R i and
47,000 for R 2), the  assum ption of 85%  recovery betw een Steps 
I  and  I I I  for bo th  factors, and  the  figure of 1015 cells per kg of 
frozen E . coli. T he  resu lt m ay be com pared w ith  the  ribosome 
conten t of 30,000 per cell which we have found in cells grown 
under the same conditions. D a ta  of Leder, Skogerson, and  N au  
(22) indicate th a t  G factor molecules, which partic ipa te  in each 
am ino acid addition  to a growing polypeptide chain, have an 
abundance exceeding th a t  of ribosomes. A g reat excess of G 
factor over release factor molecules is consistent w ith  the  fact 
th a t  the  elongation step occurs m any  tim es and  the  release step 
only once in the  synthesis of a polypeptide chain.
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